The global pharmaceutical glass packaging market size reached US$ 8.05 Billion in 2021. It is projected to reach a value of US$ 12.63 Billion by 2027 exhibiting a CAGR of 7.40% during 2022-2027.
Packaging represents the process of ensuring security, distinctive appearance, identification, information convenience, and compliance for goods during storage, transportation, and display. Some widely utilized pharmaceutical glass packaging solutions include ultra-resistant borosilicate glass, surface treated soda-lime glass, regular soda-lime glass, etc. They aid in eliminating the risk of contamination of the medicines.
Pharmaceutical glass packaging also assists in extending the shelf life of pharmaceutical products and prevents the escape of volatile ingredients, thereby increasing the drug stability. Apart from this, colored glass, such as amber and red-colored glass, is also utilized to protect the contents from ultraviolet rays and specific wavelengths.
Global Pharmaceutical Glass Packaging Industry Trends and Drivers:
The expanding pharmaceutical sector is one of the primary factors driving the pharmaceutical glass packaging market. In line with this, the elevating requirement for generic drugs and injectables is further catalyzing the product demand. Additionally, the inflating prevalence of chronic diseases, such as diabetes, and the growing consumer health consciousness are further propelling the market growth.
Request a Free Sample PDF of the Report: https://www.imarcgroup.com/pharmaceutical-glass-packaging-market/requestsample
Besides this, government bodies of numerous countries are launching various initiatives to encourage the usage of recycled glass to minimize the carbon footprint and ensure a safer and greener environment, which is also positively influencing the global market.
Moreover, the introduction of thin and lightweight glass bottles by key market players to reduce the consumption of raw materials and energy is anticipated to bolster the pharmaceutical glass packaging market in the coming years.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Ardagh Group S.A, Beatson Clark, Bormioli Pharma S.p.A., Corning Incorporated, Gerresheimer AG, Nipro Corporation, Piramal Enterprises Ltd., Schott AG, SGD Pharma, Shandong Pharmaceutical Glass Co. Ltd., Stölzle-Oberglas GmBH and West Pharmaceutical Services Inc.
The report has segmented the market on the basis of region, product, drug type and application.
Breakup by Product:
Bottles
Vials
Ampoules
Cartridges and Syringes
Others
Breakup by Drug Type:
Generic
Branded
Biologic
Breakup by Application:
Oral
Injectable
Nasal
Others
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Also read: Time And Attendance Software Market is Set for Strong Growth and Reach Around US$ 4.16 Billion by 2027
